Sector News

Categories

Borderless Insights

Image
How to impress the headhunter: Andrew Kris in conversation with Anthony Harling provide the clues.
Image
Now performing in the biotech big top: The Chief Medical Officer
Image
What can the Life Sciences sector and other industries learn from Amazon

Takeda US president quits

November 25, 2014
Life sciences
The president of Japanese drug major Takeda Pharmaceutical’s (TYO: 4502) US subsidiary, Douglas Cole, has resigned, after 22 years with the company.
 
Mr Cole, aged 47, “is at a point in his career where he decided to explore his options,” company spokeswoman Sandy Rodriguez told Crain’s Chicago Business. He plans to remain with the company until the end of its fiscal year, March 31, 2015, or until a successor is named.
 

Related News

April 10, 2021

Genentech aims high with new diversity goals, including doubling hires and spending $1B with diverse suppliers

Life sciences

Quita Highsmith, Genentech’s chief diversity officer, is helping the pharma double down on diversity and inclusion goals with a new 2025 plan. 

Read more
April 10, 2021

Merck CEO Frazier joins army of Black execs speaking out on restrictive voting-rights laws

Life sciences

Merck CEO Kenneth Frazier teamed up with former American Express executive Kenneth Chenault to protest a voting-rights law passed recently in Georgia.

Read more
April 10, 2021

Zimmer Biomet bundles robotic surgery, apps and digital health programs into one orthopedics package

Life sciences

By bringing together big data and robotic procedures, the ultimate goal of the connected suite is to take some of the guesswork out of orthopedic medicine. 

Read more
More news
Send this to a friend